Ryan Setten

Title(s)Postdoctoral Scholar, Cellular and Molecular Medicine
SchoolVc-health Sciences-schools
Address9500 Gilman Drive #
La Jolla CA 92093
vCardDownload vCard

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Delivery of RNA Therapeutics: The Great Endosomal Escape! Nucleic Acid Ther. 2022 May 24. Dowdy SF, Setten RL, Cui XS, Jadhav SG. PMID: 35612432.
      View in: PubMed   Mentions:
    2. CRED9: A differentially expressed elncRNA regulates expression of transcription factor CEBPA. RNA. 2021 May 26. Setten RL, Chomchan P, Epps EW, Burnett JC, Rossi JJ. PMID: 34039742; PMCID: PMC8284328.
      View in: PubMed   Mentions:    Fields:    
    3. Author Correction: The current state and future directions of RNAi-based therapeutics. Nat Rev Drug Discov. 2020 04; 19(4):290. Setten RL, Rossi JJ, Han SP. PMID: 31019276.
      View in: PubMed   Mentions: 1     Fields:    
    4. Publisher Correction: The current state and future directions of RNAi-based therapeutics. Nat Rev Drug Discov. 2020 04; 19(4):291. Setten RL, Rossi JJ, Han SP. PMID: 30886427.
      View in: PubMed   Mentions:    Fields:    
    5. The current state and future directions of RNAi-based therapeutics. Nat Rev Drug Discov. 2019 06; 18(6):421-446. Setten RL, Rossi JJ, Han SP. PMID: 30846871.
      View in: PubMed   Mentions: 184     Fields:    Translation:HumansAnimals
    6. Development of MTL-CEBPA: Small Activating RNA Drug for Hepatocellular Carcinoma. Curr Pharm Biotechnol. 2018; 19(8):611-621. Setten RL, Lightfoot HL, Habib NA, Rossi JJ. PMID: 29886828; PMCID: PMC6204661.
      View in: PubMed   Mentions: 8     Fields:    Translation:HumansAnimalsCells
    7. G9a/GLP-dependent H3K9me2 patterning alters chromatin structure at CpG islands in hematopoietic progenitors. Epigenetics Chromatin. 2014; 7:23. Schones DE, Chen X, Trac C, Setten R, Paddison PJ. PMID: 25237399; PMCID: PMC4166411.
      View in: PubMed   Mentions: 10     Fields:    
    8. Open chromatin profiling in mice livers reveals unique chromatin variations induced by high fat diet. J Biol Chem. 2014 Aug 22; 289(34):23557-67. Leung A, Parks BW, Du J, Trac C, Setten R, Chen Y, Brown K, Lusis AJ, Natarajan R, Schones DE. PMID: 25006255; PMCID: PMC4156056.
      View in: PubMed   Mentions: 25     Fields:    Translation:AnimalsCells
    9. Persistent inhibition of ABL tyrosine kinase causes enhanced apoptotic response to TRAIL and disrupts the pro-apoptotic effect of chloroquine. PLoS One. 2013; 8(10):e77495. Sridevi P, Nhiayi MK, Setten RL, Wang JY. PMID: 24147007; PMCID: PMC3795698.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCells
    Ryan's Networks
    Concepts (39)
    Derived automatically from this person's publications.
    Co-Authors (3)
    People in Profiles who have published with this person.
    Similar People (60)
    People who share similar concepts with this person.
    Same Department
    Search Department